|
|
|
|
| LEADER |
01080nom a2200301 u 4500 |
| 001 |
10093779 |
| 003 |
upatras |
| 005 |
20210117203013.0 |
| 008 |
110802s2010 eng |
| 020 |
|
|
|a 9781441910875
|
| 040 |
|
|
|a GR-PaULI
|c GR-PaULI
|
| 041 |
0 |
|
|a eng
|
| 100 |
1 |
|
|a Kulshreshtha, Alok K
|9 100218
|
| 245 |
1 |
0 |
|a Pharmaceutical Suspensions
|h [electronic resource]
|b From Formulation Development to Manufacturing
|c edited by Alok K. Kulshreshtha, Onkar N. Singh, G. Michael Wall
|
| 260 |
|
|
|a New York, NY
|b Springer-Verlag New York
|c 2010
|
| 300 |
|
|
|b v.: digital
|
| 650 |
|
4 |
|a Medicine
|9 11026
|
| 650 |
|
4 |
|a Toxicology
|9 13539
|
| 650 |
|
4 |
|a Biomedicine
|9 64032
|
| 650 |
|
4 |
|a Pharmacology/Toxicology
|9 64073
|
| 700 |
1 |
|
|a Singh, Onkar N
|9 100219
|
| 700 |
1 |
|
|a Wall, G. Michael
|9 100220
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|9 68735
|
| 852 |
|
|
|a GR-PaULI
|b ΠΑΤΡΑ
|b ΒΚΠ
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1007/978-1-4419-1087-5
|
| 942 |
|
|
|2 ddc
|
| 952 |
|
|
|0 0
|1 0
|4 0
|7 0
|9 101693
|a LISP
|b LISP
|d 2016-04-24
|l 0
|r 2016-04-24 00:00:00
|w 2016-04-24
|y ERS
|
| 999 |
|
|
|c 69479
|d 69479
|
